Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease
Top Cited Papers
- 1 March 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (5), 1934-1936
- https://doi.org/10.1182/blood-2003-06-1919
Abstract
Cardiac T2* (magnetic resonance imaging relaxation parameter) is abnormally low in approximately 40% of adults with thalassemia major (TM), suggesting myocardial iron deposition, but it is unknown at what age this occurs. To address this question, we measured cardiac T2* and function in 19 young patients (aged 7-26 years) with TM as well as 17 patients receiving long-term transfusions for sickle cell anemia (SCA) matched for age, sex, and liver iron content. Cardiac T2* was normal in all of the SCA patients but was low (high iron) in 8 of 19 TM patients. Abnormal T2* was observed only in the TM patients receiving transfusions for 13 years or longer and was correlated with ferritin but not liver iron levels. Cardiac dysfunction was present in 3 of the 8 patients with low T2*. Cardiac T2* changes have a long latency relative to liver iron accumulation. Total transfusional burden is a significant independent risk factor for low cardiac T2* and may partially account for differences observed between patients with SCA and TM.Keywords
This publication has 23 references indexed in Scilit:
- Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron poolBlood, 2003
- Cardiac abnormalities in children with sickle cell anemiaAmerican Journal of Hematology, 2002
- Current issues with blood transfusions in sickle cell diseaseSeminars in Hematology, 2001
- Current issues with blood transfusions in sickle cell diseaseSeminars in Hematology, 2001
- Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia RegisterThe Lancet, 2000
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Prolonged survival in patients with beta-thalassemia major treated with deferoxamineThe Journal of Pediatrics, 1991
- EVALUATION OF CARDIAC FUNCTION IN PATIENTS WITH THALASSEMIA MAJORAnnals of the New York Academy of Sciences, 1980
- Cardiac conduction system in hemochromatosis: Clinical and pathologic features of six patientsThe American Journal of Cardiology, 1979
- Iron in the heartThe American Journal of Medicine, 1971